Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Carprofen
Cat. No.:
0225LY-0525
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, and HPLC.
Size:
Add to basket
Product Overview
Description:
Carprofen is a propionic acid-based nonsteroidal anti-inflammatory drug (NSAID) used for its antipyretic, analgesic, and anti-inflammatory properties.
Synonym:
Ridamyl; Imadyl; Rimadyl; 53716-49-7; 2-(6-Chloro-9H-carbazol-2-yl)propanoic acid; (2RS)-2-(6-Chloro-9H-carbazol-2-yl)propanoic acid
CAS No.:
53716-49-7
Compound CID:
2581
Formula:
C15H12ClNO2
Formula Weight:
273.71
Specification
Targets&IC50:
COX-2 (canine): 30 nM
Relative Density:
1.42 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Carprofen can be used in veterinary and comparative medicine research to examine the regulation of COX-2-mediated inflammation.
Library Information
Target:
COX; FAAH
Receptor:
COX-2; FAAH
Pathways:
Neuronal signaling; Autophagy; Immunology/Inflammation; Metabolism
Plate Number:
AOCL-7
Plate Location:
g8
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10mM DMSO
DMSO Max Solubility:
123 mg/mL; 449.38 mM
Water Max Solubility:
<1 mg/mL (insoluble or slightly soluble)
Ethanol Max Solubility:
51 mg/mL; 186.33 mM
